In today’s news reports we cover items on: Prediction of risk for prostate cancer under-grading based on biopsy data The obesity/risk equation in prostate cancer Capecitabine + docetaxel in met… more →
THE "NEW" PROSTATE CANCER INFOLINKSitemaster wrote 4 days ago: In today’s news reports we cover items on: Prediction of risk for prostate cancer under-gradi … more →
Sitemaster wrote 5 days ago: In todayas news reports we deal with items about: Celecoxib therapy prior to radical prostatectomy … more →
Sitemaster wrote 1 week ago: A report in this week’s issue of the New England Journal of Medicine (which is never shy about … more →
Sitemaster wrote 1 week ago: Today’s news reports include discussion of items on: Prostate cancer risk awareness Improving … more →
Sitemaster wrote 1 week ago: OncoGenex Pharmaceuticals has just announced today that the company is “ready to proceed with … more →
Sitemaster wrote 2 weeks ago: According to a report on WebMD, presumably based on media information provided by the Mayo Clinic, t … more →
Sitemaster wrote 2 weeks ago: Articles addressed in this report deal with: The reactions of men to a diagnosis of prostate cancer … more →
Sitemaster wrote 2 weeks ago: One of the major issues in the management of prostate cancer is the identification of early physical … more →
Sitemaster wrote 2 weeks ago: This morning’s news reports address: Patterns of use of PSA and DRE testing in the USA The va … more →
Sitemaster wrote 3 weeks ago: Today’s news reports include information on: Outcomes comparing two types of radiation therap … more →
Sitemaster wrote 3 weeks ago: According to a report today on NJ.com, there are suggestions that defective “autophagy” … more →
Sitemaster wrote 3 weeks ago: Today’s news reports deal with items on: The mechanism of action of D,L-sulforaphane Isolatio … more →
Sitemaster wrote 1 month ago: Because it takes so long for men with even advanced prostate cancer to progress through to death fro … more →
Sitemaster wrote 1 month ago: Bristol-Myers Squibb has announced the launch of the READY Phase III trial designed to compared dasa … more →
Sitemaster wrote 1 month ago: At a meeting of some leading members of the prostate cancer advocacy community yesterday morning, du … more →
Sitemaster wrote 1 month ago: There were about 50 prostate cancer-specific posters presented in the general poster session on Sund … more →
Sitemaster wrote 1 month ago: There were probably over 100 posters related to prostate cancer presented at the ASCO meeting today … more →
Sitemaster wrote 1 month ago: On Saturday there were two major prostate cancer sessions and additional poster sessions that includ … more →
Sitemaster wrote 1 month ago: Every so often you come across something so far “out of left field” that just possibly … more →